AIM-listed AVO is using technology developed by scientists working on the large hadron collider at the CERN facility in Switzerland to create a low-cost proton-beam treatment for cancer. Its shares climbed almost 5% on today’s news, which represents the final piece of the funding jigsaw for the Harley Street unit, which will be operated by Circle healthcare. The centre will open next year.